石四药集团有限公司（02005）于2026年3月2日发布2026年2月股份变动月报表，报告期截至2026年2月28日。根据公告披露，公司本月无新增股份发行、购回或注销，整体股本结构保持不变。
公司自公布日上月底至本月底，法定/注册股本维持为100亿股，面值每股0.02港元，总额约2亿港元。已发行股份（不含库存股份）数量保持在2,899,243,385股，库存股份数量为51,870,000股，合计股份总数2,951,113,385股。
根据公告，公司已于2023年1月13日采纳的二零二三年购股权计划在本月无期权行使或变动，期末可行使期权对应股份数为297,268,338股。公司确认目前公众持股量符合香港联交所规定。
公告由执行董事兼公司秘书周兴扬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.